This thesis aims to capture patient perceptions of adoption and use of insulin pumps (IP) and continuous glucose monitors (CGM). The first two phases were dedicated to identify barriers and benefits of adoption of IP and CGM respectively. Four themes were identified in the insulin pump study: 1. the lack of value add to management, 2. the psychosocial impact, 3. requirement of a support structure during adoption, 4. need for behavioural readjustment for success. In the CGM phase, three themes were identified: 1. frustrations, 2. data promotes and proactivity, 3. cost/benefit analysis as a substantial barrier to adoption.In the third phase, a usability study of the five insulin pumps on the North American market was conducted. Ultimat...
Background: Diabetes is a threat to peoples’ lives around the world, particularly in the Middle East...
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important...
OBJECTIVES: To identify and survey health care professionals (HCPs) attitudes to insulin pump therap...
This thesis aims to capture patient perceptions of adoption and use of insulin pumps (IP) and contin...
Real-time continuous glucose monitoring is associated with significant benefits for diabetes managem...
The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many t...
Background: Approximately 122 million Americans have diabetes or prediabetes. In 2018, 8.7% of adult...
Introduction: Continuous subcutaneous insulin infusion with an insulin pump provides best practice f...
Goal The goal of this CE module is to provide pharmacists with an overview of the use of insulin pum...
Background: While multiple daily insulin injections remains the state-of-the-art treatment for type ...
Insulin pumps are designed for the self-management of diabetes mellitus in patients and are known fo...
Insulin pumps are designed for the self-management of diabetes in patients and are known for their c...
Psychological and physical factors are barriers to insulin therapy adherence. Insulin delivery devic...
Insulin pumps are designed for the self-management of diabetes mellitus in patients and are known fo...
Continuous Glucose Monitoring Systems (CGMs) device is the most developed technology, which has resh...
Background: Diabetes is a threat to peoples’ lives around the world, particularly in the Middle East...
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important...
OBJECTIVES: To identify and survey health care professionals (HCPs) attitudes to insulin pump therap...
This thesis aims to capture patient perceptions of adoption and use of insulin pumps (IP) and contin...
Real-time continuous glucose monitoring is associated with significant benefits for diabetes managem...
The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many t...
Background: Approximately 122 million Americans have diabetes or prediabetes. In 2018, 8.7% of adult...
Introduction: Continuous subcutaneous insulin infusion with an insulin pump provides best practice f...
Goal The goal of this CE module is to provide pharmacists with an overview of the use of insulin pum...
Background: While multiple daily insulin injections remains the state-of-the-art treatment for type ...
Insulin pumps are designed for the self-management of diabetes mellitus in patients and are known fo...
Insulin pumps are designed for the self-management of diabetes in patients and are known for their c...
Psychological and physical factors are barriers to insulin therapy adherence. Insulin delivery devic...
Insulin pumps are designed for the self-management of diabetes mellitus in patients and are known fo...
Continuous Glucose Monitoring Systems (CGMs) device is the most developed technology, which has resh...
Background: Diabetes is a threat to peoples’ lives around the world, particularly in the Middle East...
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important...
OBJECTIVES: To identify and survey health care professionals (HCPs) attitudes to insulin pump therap...